Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CDXS · against 115 other Healthcare companies of similar size
Ranked #81 of 116 · scores higher than 5% of peers
Bars: peers in each 10-point band of the valuation score36 peers with a valuation score of 0–9, including CDXS · Click a bar to see the companies
Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | CDXS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 99 reported | -30.6% | -11.7% | 37% | 30% | |
| EBITDA yieldHigher is better · 123 reported | -14.0% | -1.0% | 32% | 50% | |
| Free cash flow yieldHigher is better · 86 reported | -10.3% | -15.2% | 58% | 20% | |
| Book yieldHigher is better · 103 reported | 33.4% | 71.5% | 30% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 81 | 201M USD | 8 | 24 | |
| 81 | 115M USD | 8 | 8 | |
| 81 | 82M USD | 8 | 27 | |
| 81 | 222M USD | 8 | 31 | |
| 81 | 118M USD | 8 | 13 | |
| 81 | 67M USD | 8 | ||
| 81 | 221M USD | 8 | 33 | |
| 81 | 234M USD | 8 | ||
| 81 | 207M USD | 8 | 41 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score